ONCOPEP

OncoPep, Inc. was founded in 2010 to commercialize a novel approach to developing targeted immunotherapeutics against cancer. The company's proprietary core technology was developed in the laboratory of Dr. Kenneth Anderson, M.D., a world leader in cancer treatment, at the Dana Farber Cancer Institute. The technology, which OncoPep has exclusively licensed from Dana Farber, employs a unique combination of proprietary peptides to form a therapeutic cancer vaccine. Vaccines developed from this technology are designed to stimulate the patient’s immune system to attack his or her cancer through an optimized combination of disease-specific peptides and adjuvants (substances that stimulate the immune system).

#SimilarOrganizations #People #Financial #Event #Website #More

ONCOPEP

Industry:

Biotechnology Health Care Pharmaceutical

Founded:

2010-01-01

Address:

North Andover, Massachusetts, United States

Country:

United States

Website Url:

http://www.oncopep.com

Total Employee:

Status:

Active

Contact:

+1 978 837 1129

Email Addresses:

[email protected]

Total Funding:

28.44 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Font Awesome Global Site Tag